Awareness of venous thromboembolism risk in cancer patients: the oncologist knowledge gap
The management of cancer-associated venous thrombosis (CAT) is particularly challenging because of a high risk of major...
Trials and Therapy
Is apixaban safe for primary VTE prevention in patients with gastrointestinal cancers? A summary of a post-hoc analysis of the AVERT trial
Patients with cancer and a Khorana score ≥2 have an estimated risk of symptomatic venous thromboembolism (VTE) of...
Investigating the drug−drug interactions occurring in cancer-associated thrombosis: use of checkpoint inhibitors and direct oral anticoagulants in a real-world setting
Advances in medicine and the possibility of keeping multiple diseases under control via medication have increased the...
The USCAT study: a retrospective non-interventional study to examine long-term treatment of CAT
Patients with cancer are at high risk of venous thromboembolism (VTE) recurrence and major bleeding (1). Most...
The Art of Managing Cancer-Associated Thrombosis: Caravaggio and Beyond
Venous thromboembolism (VTE) is a frequent complication and the second leading cause of death in cancer patients....
Toward the replacement of low-molecular-weight heparins with the novel direct oral anticoagulants for the treatment of cancer-associated thrombosis
Value and limitations of low-molecular-weight heparins Following the demonstration that vitamin K antagonists (VKA) are...
Incidental venous thromboembolism in cancer patients
It is well known that patients with cancer are at high risk of venous thromboembolism (VTE), especially when initiating...
Platelet Cut-Off for Anticoagulant Therapy in Thrombocytopenic Patients with Blood Cancer and Venous Thromboembolism
Venous thromboembolism (VTE) is a recurrent risk factor in cancer patients. In particular, patients with hematologic...
Isolated Distal DVT In Cancer Patients: What Do Recent Studies Suggest?
In a recent issue of the Journal of Thrombosis and Hemostasis, we report that cancer patients with isolated distal deep...
Direct oral anticoagulants for the treatment of cancer-associated thrombosis
Cancer-associated venous thromboembolism (VTE) is known to impact up to one-fifth of patients with cancer. The...